{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:13:48Z","timestamp":1790741628092,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13024-015-0063-2","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T18:44:29Z","timestamp":1449686669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["The N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington\u2019s disease model"],"prefix":"10.1186","volume":"10","author":[{"given":"Matthew B.","family":"Veldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesenia","family":"Rios-Galdamez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. William","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,9]]},"reference":[{"key":"63_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-52014-2.00001-X","volume":"100","author":"KM Shannon","year":"2011","unstructured":"Shannon KM. Huntington\u2019s disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis. Handb Clin Neurol. 2011;100:3\u201313.","journal-title":"Handb Clin Neurol"},{"key":"63_CR2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol. 2014;10:204\u201316.","journal-title":"Nat Rev Neurol"},{"key":"63_CR3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. Lancet. 2007;369:218\u201328.","journal-title":"Lancet"},{"key":"63_CR4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci. 2007;30:575\u2013621.","journal-title":"Annu Rev Neurosci"},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","volume":"100","author":"JP Vonsattel","year":"2011","unstructured":"Vonsattel JP, Keller C, Cortes Ramirez EP. Huntington\u2019s disease - neuropathology. Handb Clin Neurol. 2011;100:83\u2013100.","journal-title":"Handb Clin Neurol"},{"key":"63_CR6","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 1993, 72:971\u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, et al. Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science. 1995;269:407\u201310.","journal-title":"Science"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue. Nat Genet. 1995;11:155\u201363.","journal-title":"Nat Genet"},{"key":"63_CR9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir J, Floresco SB, O\u2019Kusky JR, Diewert VM, Richman JM, Zeisler J, et al. Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell. 1995;81:811\u201323.","journal-title":"Cell"},{"key":"63_CR10","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997;277:1990\u20133.","journal-title":"Science"},{"key":"63_CR11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997;90:537\u201348.","journal-title":"Cell"},{"key":"63_CR12","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, et al. Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology. J Neurosci. 1999;19:2522\u201334.","journal-title":"J Neurosci"},{"key":"63_CR13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431:805\u201310.","journal-title":"Nature"},{"key":"63_CR14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/mcne.1999.0773","volume":"14","author":"MF Peters","year":"1999","unstructured":"Peters MF, Nucifora FC, Kushi J, Seaman HC, Cooper JK, Herring WJ, et al. Nuclear targeting of mutant Huntingtin increases toxicity. Mol Cell Neurosci. 1999;14:121\u20138.","journal-title":"Mol Cell Neurosci"},{"key":"63_CR15","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/hmg\/ddh175","volume":"13","author":"G Schilling","year":"2004","unstructured":"Schilling G, Savonenko AV, Klevytska A, Morton JL, Tucker SM, Poirier M, et al. Nuclear-targeting of mutant huntingtin fragments produces Huntington\u2019s disease-like phenotypes in transgenic mice. Hum Mol Genet. 2004;13:1599\u2013610.","journal-title":"Hum Mol Genet"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pneurobio.2006.11.004","volume":"83","author":"R Truant","year":"2007","unstructured":"Truant R, Atwal RS, Burtnik A. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington\u2019s disease. Prog Neurobiol. 2007;83:211\u201327.","journal-title":"Prog Neurobiol"},{"key":"63_CR17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1092194","volume":"304","author":"JS Steffan","year":"2004","unstructured":"Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, et al. SUMO modification of Huntingtin and Huntington\u2019s disease pathology. Science. 2004;304:100\u20134.","journal-title":"Science"},{"key":"63_CR18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/molbev\/msm258","volume":"25","author":"M Tartari","year":"2008","unstructured":"Tartari M, Gissi C, Lo Sardo V, Zuccato C, Picardi E, Pesole G, et al. Phylogenetic comparison of huntingtin homologues reveals the appearance of a primitive polyQ in sea urchin. Mol Biol Evol. 2008;25:330\u20138.","journal-title":"Mol Biol Evol"},{"key":"63_CR19","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","volume":"16","author":"RS Atwal","year":"2007","unstructured":"Atwal RS, Xia J, Pinchev D, Taylor J, Epand RM, Truant R. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum Mol Genet. 2007;16:2600\u201315.","journal-title":"Hum Mol Genet"},{"key":"63_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/hmg\/ddl440","volume":"16","author":"E Rockabrand","year":"2007","unstructured":"Rockabrand E, Slepko N, Pantalone A, Nukala VN, Kazantsev A, Marsh JL, et al. The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet. 2007;16:61\u201377.","journal-title":"Hum Mol Genet"},{"key":"63_CR21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.str.2009.08.002","volume":"17","author":"MW Kim","year":"2009","unstructured":"Kim MW, Chelliah Y, Kim SW, Otwinowski Z, Bezprozvanny I. Secondary structure of Huntingtin amino-terminal region. Structure. 2009;17:1205\u201312.","journal-title":"Structure"},{"key":"63_CR22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1021\/bi301325q","volume":"52","author":"M Michalek","year":"2013","unstructured":"Michalek M, Salnikov ES, Werten S, Bechinger B. Membrane interactions of the amphipathic amino terminus of huntingtin. Biochemistry. 2013;52:847\u201358.","journal-title":"Biochemistry"},{"key":"63_CR23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nsmb.1570","volume":"16","author":"AK Thakur","year":"2009","unstructured":"Thakur AK, Jayaraman M, Mishra R, Thakur M, Chellgren VM, Byeon IJ, et al. Polyglutamine disruption of the huntingtin exon 1\u00a0N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol. 2009;16:380\u20139.","journal-title":"Nat Struct Mol Biol"},{"key":"63_CR24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nsmb.1700","volume":"16","author":"S Tam","year":"2009","unstructured":"Tam S, Spiess C, Auyeung W, Joachimiak L, Chen B, Poirier MA, et al. The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation. Nat Struct Mol Biol. 2009;16:1279\u201385.","journal-title":"Nat Struct Mol Biol"},{"key":"63_CR25","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1111\/febs.12418","volume":"280","author":"CY Lee","year":"2013","unstructured":"Lee CY, Cantle JP, Yang XW. Genetic manipulations of mutant huntingtin in mice: new insights into Huntington\u2019s disease pathogenesis. FEBS J. 2013;280:4382\u201394.","journal-title":"FEBS J"},{"key":"63_CR26","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200909067","volume":"187","author":"LM Thompson","year":"2009","unstructured":"Thompson LM, Aiken CT, Kaltenbach LS, Agrawal N, Illes K, Khoshnan A, et al. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol. 2009;187:1083\u201399.","journal-title":"J Cell Biol"},{"key":"63_CR27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","volume":"64","author":"X Gu","year":"2009","unstructured":"Gu X, Greiner ER, Mishra R, Kodali R, Osmand A, Finkbeiner S, et al. Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron. 2009;64:828\u201340.","journal-title":"Neuron"},{"key":"63_CR28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.neuron.2015.01.008","volume":"85","author":"X Gu","year":"2015","unstructured":"Gu X, Cantle JP, Greiner ER, Lee CY, Barth AM, Gao F, et al. N17 Modifies Mutant Huntingtin Nuclear Pathogenesis and Severity of Disease in HD BAC Transgenic Mice. Neuron. 2015;85:726\u201341.","journal-title":"Neuron"},{"key":"63_CR29","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andr\u00e9 VM, Wilburn B, Lu XH, et al. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci. 2008;28:6182\u201395.","journal-title":"J Neurosci"},{"key":"63_CR30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","volume":"69","author":"ZR Crook","year":"2011","unstructured":"Crook ZR, Housman D. Huntington\u2019s disease: can mice lead the way to treatment? Neuron. 2011;69:423\u201335.","journal-title":"Neuron"},{"key":"63_CR31","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","volume":"285","author":"C Landles","year":"2010","unstructured":"Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, Finkbeiner S, et al. Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem. 2010;285:8808\u201323.","journal-title":"J Biol Chem"},{"key":"63_CR32","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam K, Neueder A, Gipson TA, Landles C, Benjamin AC, Bondulich MK, et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A. 2013;110:2366\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"63_CR33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87:493\u2013506.","journal-title":"Cell"},{"key":"63_CR34","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1073\/pnas.97.4.1589","volume":"97","author":"S Krobitsch","year":"2000","unstructured":"Krobitsch S, Lindquist S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci U S A. 2000;97:1589\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"63_CR35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1073\/pnas.96.1.179","volume":"96","author":"PW Faber","year":"1999","unstructured":"Faber PW, Alter JR, MacDonald ME, Hart AC. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci U S A. 1999;96:179\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"63_CR36","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1073\/pnas.231476398","volume":"98","author":"JA Parker","year":"2001","unstructured":"Parker JA, Connolly JB, Wellington C, Hayden M, Dausset J, Neri C. Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc Natl Acad Sci U S A. 2001;98:13318\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"63_CR37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0896-6273(00)80573-5","volume":"21","author":"GR Jackson","year":"1998","unstructured":"Jackson GR, Salecker I, Dong X, Yao X, Arnheim N, Faber PW, et al. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron. 1998;21:633\u201342.","journal-title":"Neuron"},{"key":"63_CR38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11910-011-0182-2","volume":"11","author":"Y Xi","year":"2011","unstructured":"Xi Y, Noble S, Ekker M. Modeling neurodegeneration in zebrafish. Curr Neurol Neurosci Rep. 2011;11:274\u201382.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"63_CR39","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1074\/jbc.M607865200","volume":"282","author":"NW Schiffer","year":"2007","unstructured":"Schiffer NW, Broadley SA, Hirschberger T, Tavan P, Kretzschmar HA, Giese A, et al. Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model. J Biol Chem. 2007;282:9195\u2013203.","journal-title":"J Biol Chem"},{"key":"63_CR40","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1523\/JNEUROSCI.3001-05.2005","volume":"25","author":"VM Miller","year":"2005","unstructured":"Miller VM, Nelson RF, Gouvion CM, Williams A, Rodriguez-Lebron E, Harper SQ, et al. CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. J Neurosci. 2005;25:9152\u201361.","journal-title":"J Neurosci"},{"key":"63_CR41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nchembio.79","volume":"4","author":"A Williams","year":"2008","unstructured":"Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, et al. Novel targets for Huntington\u2019s disease in an mTOR-independent autophagy pathway. Nat Chem Biol. 2008;4:295\u2013305.","journal-title":"Nat Chem Biol"},{"key":"63_CR42","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1002\/dvdy.21343","volume":"236","author":"KM Kwan","year":"2007","unstructured":"Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, Campbell DS, et al. The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn. 2007;236:3088\u201399.","journal-title":"Dev Dyn"},{"key":"63_CR43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1474-9726.2007.00278.x","volume":"6","author":"SB Tsai","year":"2007","unstructured":"Tsai SB, Tucci V, Uchiyama J, Fabian NJ, Lin MC, Bayliss PE, et al. Differential effects of genotoxic stress on both concurrent body growth and gradual senescence in the adult zebrafish. Aging Cell. 2007;6:209\u201324.","journal-title":"Aging Cell"},{"key":"63_CR44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JHD-130058","volume":"2","author":"L Zeng","year":"2013","unstructured":"Zeng L, Tallaksen-Greene SJ, Wang B, Albin RL, Paulson HL. The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease. J Huntingtons Dis. 2013;2:201\u201315.","journal-title":"J Huntingtons Dis"},{"key":"63_CR45","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/hmg\/dds554","volume":"22","author":"T Maiuri","year":"2013","unstructured":"Maiuri T, Woloshansky T, Xia J, Truant R. The huntingtin N17 domain is a multifunctional CRM1 and Ran-dependent nuclear and cilial export signal. Hum Mol Genet. 2013;22:1383\u201394.","journal-title":"Hum Mol Genet"},{"key":"63_CR46","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/hmg\/10.21.2425","volume":"10","author":"K Sathasivam","year":"2001","unstructured":"Sathasivam K, Woodman B, Mahal A, Bertaux F, Wanker EE, Shima DT, et al. Centrosome disorganization in fibroblast cultures derived from R6\/2 Huntington\u2019s disease (HD) transgenic mice and HD patients. Hum Mol Genet. 2001;10:2425\u201335.","journal-title":"Hum Mol Genet"},{"key":"63_CR47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12035-009-8097-5","volume":"41","author":"HY Hsiao","year":"2010","unstructured":"Hsiao HY, Chern Y. Targeting glial cells to elucidate the pathogenesis of Huntington\u2019s disease. Mol Neurobiol. 2010;41:248\u201355.","journal-title":"Mol Neurobiol"},{"key":"63_CR48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nn.3668","volume":"17","author":"A Crotti","year":"2014","unstructured":"Crotti A, Benner C, Kerman BE, Gosselin D, Lagier-Tourenne C, Zuccato C, et al. Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci. 2014;17:513\u201321.","journal-title":"Nat Neurosci"},{"key":"63_CR49","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1152\/ajpendo.00630.2010","volume":"301","author":"P She","year":"2011","unstructured":"She P, Zhang Z, Marchionini D, Diaz WC, Jetton TJ, Kimball SR, et al. Molecular characterization of skeletal muscle atrophy in the R6\/2 mouse model of Huntington\u2019s disease. Am J Physiol Endocrinol Metab. 2011;301:E49\u201361.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"63_CR50","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejphar.2012.10.026","volume":"698","author":"A Rahman","year":"2013","unstructured":"Rahman A, Ekman M, Shakirova Y, Andersson KE, M\u00f6rgelin M, Erjef\u00e4lt JS, et al. Late onset vascular dysfunction in the R6\/1 model of Huntington\u2019s disease. Eur J Pharmacol. 2013;698:345\u201353.","journal-title":"Eur J Pharmacol"},{"key":"63_CR51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","volume":"250","author":"CY Lin","year":"2013","unstructured":"Lin CY, Hsu YH, Lin MH, Yang TH, Chen HM, Chen YC, et al. Neurovascular abnormalities in humans and mice with Huntington\u2019s disease. Exp Neurol. 2013;250:20\u201330.","journal-title":"Exp Neurol"},{"key":"63_CR52","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm.3514","volume":"20","author":"N Wang","year":"2014","unstructured":"Wang N, Gray M, Lu XH, Cantle JP, Holley SM, Greiner E, et al. Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington\u2019s disease. Nat Med. 2014;20:536\u201341.","journal-title":"Nat Med"},{"key":"63_CR53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/dbio.2000.9898","volume":"227","author":"HC Park","year":"2000","unstructured":"Park HC, Kim CH, Bae YK, Yeo SY, Kim SH, Hong SK, et al. Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Dev Biol. 2000;227:279\u201393.","journal-title":"Dev Biol"},{"key":"63_CR54","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.modgep.2006.04.006","volume":"6","author":"RL Bernardos","year":"2006","unstructured":"Bernardos RL, Raymond PA. GFAP transgenic zebrafish. Gene Expr Patterns. 2006;6:1007\u201313.","journal-title":"Gene Expr Patterns"},{"key":"63_CR55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/dvdy.10273","volume":"227","author":"B Ju","year":"2003","unstructured":"Ju B, Chong SW, He J, Wang X, Xu Y, Wan H, et al. Recapitulation of fast skeletal muscle development in zebrafish by transgenic expression of GFP under the mylz2 promoter. Dev Dyn. 2003;227:14\u201326.","journal-title":"Dev Dyn"},{"key":"63_CR56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/CIRCRESAHA.111.251298","volume":"110","author":"MB Veldman","year":"2012","unstructured":"Veldman MB, Lin S. Etsrp\/Etv2 is directly regulated by Foxc1a\/b in the zebrafish angioblast. Circ Res. 2012;110:220\u20139.","journal-title":"Circ Res"},{"key":"63_CR57","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1242\/jeb.048876","volume":"214","author":"FA Issa","year":"2011","unstructured":"Issa FA, O\u2019Brien G, Kettunen P, Sagasti A, Glanzman DL, Papazian DM. Neural circuit activity in freely behaving zebrafish (Danio rerio). J Exp Biol. 2011;214:1028\u201338.","journal-title":"J Exp Biol"},{"key":"63_CR58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","volume":"12","author":"S H\u00f6rsten von","year":"2003","unstructured":"von H\u00f6rsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, et al. Transgenic rat model of Huntington\u2019s disease. Hum Mol Genet. 2003;12:617\u201324.","journal-title":"Hum Mol Genet"},{"key":"63_CR59","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet. 2003;12:1555\u201367.","journal-title":"Hum Mol Genet"},{"key":"63_CR60","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","volume":"46","author":"X Gu","year":"2005","unstructured":"Gu X, Li C, Wei W, Lo V, Gong S, Li SH, et al. Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron. 2005;46:433\u201344.","journal-title":"Neuron"},{"key":"63_CR61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-2-8","volume":"2","author":"X Gu","year":"2007","unstructured":"Gu X, Andr\u00e9 VM, Cepeda C, Li SH, Li XJ, Levine MS, et al. Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington\u2019s disease. Mol Neurodegener. 2007;2:8.","journal-title":"Mol Neurodegener"},{"key":"63_CR62","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1074\/jbc.M112.413575","volume":"288","author":"Z Zheng","year":"2013","unstructured":"Zheng Z, Li A, Holmes BB, Marasa JC, Diamond MI. An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1. J Biol Chem. 2013;288:6063\u201371.","journal-title":"J Biol Chem"},{"key":"63_CR63","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0092-8674(00)80464-X","volume":"91","author":"JM Ordway","year":"1997","unstructured":"Ordway JM, Tallaksen-Greene S, Gutekunst CA, Bernstein EM, Cearley JA, Wiener HW, et al. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell. 1997;91:753\u201363.","journal-title":"Cell"},{"key":"63_CR64","volume-title":"The zebrafish book: a guide for the laboratory use of zebrafish (Brachydanio rerio)","author":"M Westerfield","year":"1993","unstructured":"Westerfield M. The zebrafish book: a guide for the laboratory use of zebrafish (Brachydanio rerio). Eugene: M. Westerfield; 1993."},{"key":"63_CR65","doi-asserted-by":"crossref","first-page":"e1001590","DOI":"10.1371\/journal.pbio.1001590","volume":"11","author":"MB Veldman","year":"2013","unstructured":"Veldman MB, Zhao C, Gomez GA, Lindgren AG, Huang H, Yang H, et al. Transdifferentiation of fast skeletal muscle into functional endothelium in vivo by transcription factor Etv2. PLoS Biol. 2013;11:e1001590.","journal-title":"PLoS Biol"},{"key":"63_CR66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1242\/dev.059345","volume":"138","author":"C Mosimann","year":"2011","unstructured":"Mosimann C, Kaufman CK, Li P, Pugach EK, Tamplin OJ, Zon LI. Ubiquitous transgene expression and Cre-based recombination driven by the ubiquitin promoter in zebrafish. Development. 2011;138:169\u201377.","journal-title":"Development"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-015-0063-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T11:56:36Z","timestamp":1599911796000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.molecularneurodegeneration.com\/content\/10\/1\/67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1186\/s13024-015-0063-2","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"67"}}